1 study on Ro7497987 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This landmark Phase Ia study provides compelling evidence that RO7497987 is safe, well-tolerated, and highly effective at expanding dendritic cell populations in healthy humans, a crucial step for boosting innate and …
Free, no account — handy when you're working with Ro7497987.